Health Check: Biotech investors reckon Trump’s tariffs may not be such a bitter pill
A better day so far, but if pain persists, keep blaming Donald Trump. Pic: Getty Images CSL shares lead the local biotech sector’s recovery Nyrada and Chimeric report their trials…